GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA and other data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company's web site at www.genego.com.
National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health
The BRC for Mental Health at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London is one of 12 national biomedical research centres created through the partnership of a leading National Health Service (NHS) provider and an outstanding university. The Centres are funded by the UK's Department of Health through the National Institute for Health Research (NIHR). The BRC for Mental Health was selected through open competition by
|SOURCE GeneGo, Inc.|
Copyright©2009 PR Newswire.
All rights reserved